U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C19H18ClN3O
Molecular Weight 339.819
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CYPRAZEPAM

SMILES

[O-][N+]1=C(C2=CC=CC=C2)C3=C(C=CC(Cl)=C3)N=C(C1)NCC4CC4

InChI

InChIKey=UKFDTMNJMKWWNK-UHFFFAOYSA-N
InChI=1S/C19H18ClN3O/c20-15-8-9-17-16(10-15)19(14-4-2-1-3-5-14)23(24)12-18(22-17)21-11-13-6-7-13/h1-5,8-10,13H,6-7,11-12H2,(H,21,22)

HIDE SMILES / InChI

Molecular Formula C19H18ClN3O
Molecular Weight 339.819
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Cyprazepam is a benzodiazepine tranquilizer, developed by Warner-Lambert Pharmaceutical Company in the 1960s. The combination of cyprazepam with pentaerythrityl tetranitrate was found advantageous for the treatment of angina pectoris.

Approval Year

Substance Class Chemical
Record UNII
933N61G4SL
Record Status Validated (UNII)
Record Version